Creatinine is a byproduct in the breakdown of muscle creatine phosphate resulting from energy metabolism. It is produced at a constant rate depending on the muscle mass of the person and is removed from the body by the kidneys. Production of creatinine is constant as long as muscle mass remains constant. A disorder of kidney function reduces excretion of creatinine, resulting in increased blood creatinine levels. Thus, creatinine levels give an approximation of the glomerular filtration rate (GFR). An estimated GFR (eGFR) can be calculated using the Modification of Diet in Renal Disease study equation, which requires a serum creatinine result, gender, age, and race.
Many laboratories are reporting the eGFR with the creatinine result.
This test diagnoses impaired kidney function. It is a more specific and sensitive indicator of kidney disease than BUN, although in CKD, both BUN and creatinine are ordered to evaluate kidney problems because the BUN-to-creatinine ratio provides more information.
Adult men: 0.91.3 mg/dL or 80115 μmol/L
Adult women: 0.61.1 mg/dL or 5397 μmol/L
Children (318 years): 0.51.0 mg/dL or 4488 μmol/L
Young children (03 years): 0.30.7 mg/dL or 2762 μmol/L
BUN-to-creatinine ratio: 10:120:1
Clinical Alert
Critical value is 10 mg/dL or 890 mol/L in patients who do not undergo dialysis
Obtain a 5-mL venous blood sample. Serum is preferred, but heparinized blood can be used. Label the specimen with the patients name, date and time of collection, and test(s) ordered. Place the specimen in a biohazard bag.
Observe standard precautions.
Increased blood creatinine levels occur in the following conditions:
Impaired kidney function
Chronic nephritis
Obstruction of urinary tract
Muscle disease
Gigantism
Acromegaly
Myasthenia gravis
Muscular dystrophy
Poliomyelitis
Heart failure
Shock
Dehydration
Rhabdomyolysis (skeletal muscle tissue breakdown)
Hyperthyroidism
Decreased creatinine levels occur in the following conditions:
Small stature
Decreased muscle mass
Advanced and severe liver disease
Inadequate dietary protein
Pregnancy (0.40.6 mg/dL or 3653 μmol/L is normal; >0.8 mg/dL or >71 μmol/L is abnormal and should be noted)
Increased ratio (>20:1) with normal creatinine occurs in the following conditions:
Increased BUN (prerenal azotemia), heart failure, salt depletion, dehydration
Catabolic states with tissue breakdown
GI hemorrhage
Impaired kidney function plus excess protein intake, production, or tissue breakdown
Increased ratio (>20:1) with elevated creatinine occurs in the following conditions:
Obstruction of urinary tract
Prerenal azotemia with kidney disease
Decreased ratio (<10:1) with decreased BUN occurs in the following conditions:
Acute tubular necrosis
Decreased urea synthesis as in severe liver disease or starvation
Repeated dialysis
SIADH
Pregnancy
Decreased ratio (<10:1) with increased creatinine occurs in the following conditions:
Phenacemide therapy (accelerates conversion of creatine to creatinine)
Rhabdomyolysis (releases muscle creatinine)
Muscular patients who develop kidney disease
Pretest Patient Care
Explain test purpose and procedure.
Assess diet for meat and protein intake.
Follow guidelines in Chapter 1 for safe, effective, informed pretest care.
Posttest Patient Care
Review test results and monitor as appropriate for impaired kidney function. Modify nursing care plan as needed.
Possible treatment includes hemodialysis and renal replacement therapy, including kidney transplant.
Follow guidelines in Chapter 1 for safe, effective, informed posttest care.
High levels of ascorbic acid and cephalosporin antibiotic drugs can cause a falsely increased creatinine level; these agents also interfere with the BUN-to-creatinine ratio.
Drugs that influence kidney function plus other medications can cause a change in the blood creatinine level (see Appendix E).
A diet high in meat can cause increased creatinine levels.
Creatinine is falsely decreased by bilirubin, glucose, histidine, and quinidine compounds.
Ketoacidosis may increase serum creatinine substantially.
Clinical Alert
Creatinine level should always be checked before administering nephrotoxic chemotherapeutic agents such as methotrexate, cisplatin, cyclophosphamide, mithramycin, and semustine